Jayson M. Rieger
Director/Board Member presso LYTIX BIOPHARMA
Posizioni attive di Jayson M. Rieger
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| LYTIX BIOPHARMA | Director/Board Member | 07/06/2021 | - |
Xalud Therapeutics, Inc.
 Xalud Therapeutics, Inc. BiotechnologyHealth Technology Xalud Therapeutics, Inc. develops novel therapies with several promising therapeutic programs for inflammatory. The firm offers XT-101, a single dosage injection that stops disease progression, eliminates neuropathic pain, and reverses paralysis. It also researches on the applicability of XT-101 for multiple sclerosis and amyotrophic lateral sclerosis. The company was founded by John Forsayeth and Linda Watkins and is headquartered in San Francisco, CA. | Director/Board Member | - | - |
PBM Capital Group LLC
 PBM Capital Group LLC Investment ManagersFinance PBM Capital Group LLC (PBM Capital Group) is a private equity and venture capital firm founded in 2010 by Paul B. Manning. The firm is headquartered in Charlottesville, Virginia. | Private Equity Investor | 01/03/2014 | - |
Storia della carriera di Jayson M. Rieger
Precedenti posizioni note di Jayson M. Rieger
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| PRECIGEN, INC. | Private Equity Investor | 01/01/2012 | 01/08/2013 |
Clinical Data, Inc.
 Clinical Data, Inc. Medical SpecialtiesHealth Technology Clinical Data, Inc. manufactured and distributed scientific instruments used in clinical and analytical laboratories. The company was founded in 1972 and was headquartered in Newton, MA. | Private Equity Investor | 01/04/2011 | 01/01/2012 |
| VERRICA PHARMACEUTICALS INC. | Director/Board Member | 01/12/2015 | - |
| Chief Operating Officer | - | - | |
Adenosine Therapeutics LLC
 Adenosine Therapeutics LLC Pharmaceuticals: MajorHealth Technology Adenosine Therapeutics LLC manufactures and develops pharmaceutical products. It provides drugs for sepsis, heart attack, vascular injury, asthma, spinal cord injury and organ transplantation. The company was founded by Joel M. Linden, George A. Beller and Robert S. Capon in 1999 and is headquartered in Charlottesville, VA. | Corporate Officer/Principal | - | - |
Formazione di Jayson M. Rieger
| University of Virginia | Doctorate Degree |
| Rollins College (Florida) | Undergraduate Degree |
| University of Virginia Darden School of Business | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 10 |
| Norvegia | 2 |
Posizioni
| Director/Board Member | 3 |
| Private Equity Investor | 3 |
| Corporate Officer/Principal | 1 |
Settori
| Health Technology | 7 |
| Consumer Services | 4 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| PRECIGEN, INC. | Health Technology |
| LYTIX BIOPHARMA | Health Technology |
| VERRICA PHARMACEUTICALS INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Clinical Data, Inc.
Clinical Data, Inc. Medical SpecialtiesHealth Technology Clinical Data, Inc. manufactured and distributed scientific instruments used in clinical and analytical laboratories. The company was founded in 1972 and was headquartered in Newton, MA. | Health Technology |
Adenosine Therapeutics LLC
Adenosine Therapeutics LLC Pharmaceuticals: MajorHealth Technology Adenosine Therapeutics LLC manufactures and develops pharmaceutical products. It provides drugs for sepsis, heart attack, vascular injury, asthma, spinal cord injury and organ transplantation. The company was founded by Joel M. Linden, George A. Beller and Robert S. Capon in 1999 and is headquartered in Charlottesville, VA. | Health Technology |
PBM Capital Group LLC
PBM Capital Group LLC Investment ManagersFinance PBM Capital Group LLC (PBM Capital Group) is a private equity and venture capital firm founded in 2010 by Paul B. Manning. The firm is headquartered in Charlottesville, Virginia. | Finance |
Xalud Therapeutics, Inc.
Xalud Therapeutics, Inc. BiotechnologyHealth Technology Xalud Therapeutics, Inc. develops novel therapies with several promising therapeutic programs for inflammatory. The firm offers XT-101, a single dosage injection that stops disease progression, eliminates neuropathic pain, and reverses paralysis. It also researches on the applicability of XT-101 for multiple sclerosis and amyotrophic lateral sclerosis. The company was founded by John Forsayeth and Linda Watkins and is headquartered in San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Jayson M. Rieger
- Esperienza
